Ranibizumab for the treatment of degenerative ocular conditions.
about
Transfer of single dose of intravitreal injection of ranibizumab and bevacizumab into milk of sheepIDO1 is an Integral Mediator of Inflammatory Neovascularization.Anti-VEGF Agents for the Treatment of Pigment Epithelial Detachments Associated with Neovascular Age-related Macular Degeneration: An Evidence-based Approach.
P2860
Ranibizumab for the treatment of degenerative ocular conditions.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Ranibizumab for the treatment of degenerative ocular conditions.
@ast
Ranibizumab for the treatment of degenerative ocular conditions.
@en
type
label
Ranibizumab for the treatment of degenerative ocular conditions.
@ast
Ranibizumab for the treatment of degenerative ocular conditions.
@en
prefLabel
Ranibizumab for the treatment of degenerative ocular conditions.
@ast
Ranibizumab for the treatment of degenerative ocular conditions.
@en
P2093
P2860
P356
P1476
Ranibizumab for the treatment of degenerative ocular conditions.
@en
P2093
Doukas Dardabounis
Horace F Massa
Irfan Perente
Konstantinos Ioannakis
Magdalini Triantafylla
Vassilios Kozobolis
P2860
P304
P356
10.2147/OPTH.S40350
P407
P577
2014-06-24T00:00:00Z